Clinical Trials · NCT06754163

Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

Name: Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Active Not RecruitingPhase 4Semaglutide

Phase: Phase 4
Recruitment status: Active Not Recruiting
Sponsor: St Andrew's Healthcare
Enrollment: 20
Start date: Jan 2025
Locations: 1 site, United Kingdom
Primary endpoint: Weight

View Semaglutide compound reference